Funovics J M, Fritsch A, Herbst F, Piza F, Mühlbacher F, Längle F, Schemper M
Department of Surgery I, University of Vienna, Medical School.
Hepatogastroenterology. 1988 Dec;35(6):316-20.
Between 1977 and 1986, 172 patients with primary hepatic cancer were treated at the Department of Surgery I, University of Vienna Medical School. In 76 cases (80%) males, 20% females), cirrhosis of the liver was also present. Ninety patients underwent curative surgery (hepatic resection in 64, and liver transplantation in 26 cases). There were no early tumor stages. Forty-five large tumors were confined to one lobe, 42 involved both lobes, 3 even invaded adjacent structures, the majority (74%) being hepatocellular carcinomas. Forty-four of the 64 liver resections were performed in patients with otherwise normal livers (mortality 18%), while 20 patients had associated liver cirrhosis. In view of the extremely high mortality rates after extended liver resection, only limited local resections have been performed in cirrhotic malignancies since 1982 (mortality 25%). Perioperative mortality (25% overall) was due mainly to hepatic failure and sepsis; non-fatal complications occurred in 12 patients (26%). Seventeen of the 26 liver transplants were cirrhotic hepatomas. Nine deaths (34%) were caused by technical problems (graft failure, clotting disorder after massive transfusion) and systemic infections. The outcome for the patient after the immediate postoperative period was determined by tumor regrowth (residual liver tissue, graft, distant metastases) in both groups (median life expectancy 18.4 months after radical liver resection and 18.6 months after liver transplantation). Surgery is the only alternative for these patients (50% survival of untreated hepatoma: 2.6 months), improving both their quality of life and survival. We believe that in carefully selected candidates with non-resectable tumors liver replacement may be a useful alternative.
1977年至1986年间,维也纳大学医学院第一外科收治了172例原发性肝癌患者。其中76例(80%)为男性,20%为女性,所有患者均伴有肝硬化。90例患者接受了根治性手术(64例行肝切除术,26例行肝移植术)。所有患者均非早期肿瘤阶段。45例大肿瘤局限于一个肝叶,42例累及两个肝叶,3例甚至侵犯了邻近结构,其中大多数(74%)为肝细胞癌。64例肝切除术中,44例患者的肝脏在其他方面正常(死亡率为18%),而20例患者伴有肝硬化。鉴于扩大肝切除术后的死亡率极高,自1982年以来,仅对肝硬化恶性肿瘤患者进行了有限的局部切除(死亡率为25%)。围手术期死亡率(总体为25%)主要归因于肝衰竭和败血症;12例患者(26%)出现非致命性并发症。26例肝移植患者中,17例为肝硬化肝癌。9例死亡(34%)是由技术问题(移植失败、大量输血后的凝血障碍)和全身感染引起的。两组患者术后近期的预后均取决于肿瘤的复发情况(残余肝组织、移植物、远处转移)(根治性肝切除术后的中位预期寿命为18.4个月,肝移植术后为18.6个月)。手术是这些患者的唯一选择(未经治疗的肝癌患者50%的生存率为2.6个月),可改善他们的生活质量和生存率。我们认为,对于精心挑选的不可切除肿瘤患者,肝移植可能是一种有效的替代方法。